Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors
Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8010-8041
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

TBAI/H2O-cooperative electrocatalytic decarboxylation coupling-annulation of quinoxalin-2(1H)-ones with N-arylglycines
Yuhan Lu, Zhuo-Tao Zhang, Hongyu Wu, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 7, pp. 108036-108036
Closed Access | Times Cited: 64
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics
Jiayu Wang, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6437-6462
Closed Access | Times Cited: 18
Paraformaldehyde as C1 Synthon: Electrochemical Three‐Component Synthesis of Tetrahydroimidazo[1,5‐a]quinoxalin‐4(5H)‐ones in Aqueous Ethanol
Yuhan Lu, Si‐Yu Mu, Jun Jiang, et al.
ChemSusChem (2023) Vol. 16, Iss. 19
Closed Access | Times Cited: 17
Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
Yiwei Zhang, Yujun Zhang, Jingjing Song, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111876-111876
Closed Access | Times Cited: 6
Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation
Sunny Goon, Chinky Shiu Chen Liu, Uddipta Ghosh Dastidar, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8225-8246
Closed Access | Times Cited: 6
4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure–property relationships and key biological targets
Angel H. Romero, Francisco Delgado
Frontiers in Chemistry (2025) Vol. 12
Open Access
Developing Engineered Nano-Immunopotentiators for the Stimulation of Dendritic Cells and Inhibition and Prevention of Melanoma
Sitah Alharthi, Seyed Zeinab Alavi, Mehr un Nisa, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 6, pp. 1163-1181
Closed Access | Times Cited: 4
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Juan Bautista De Sanctis, Jaime Charris, Zuleyma Blanco, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 10, pp. 1122-1144
Closed Access | Times Cited: 18
Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
Run Zheng, Jian Ma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2285-2285
Open Access | Times Cited: 18
Advances in polyphenol-based carbon dots for biomedical engineering applications
Jeong‐Min Han, JinWoo Hong, Hyo‐Jun Lee, et al.
European Polymer Journal (2023) Vol. 197, pp. 112354-112354
Closed Access | Times Cited: 11
Small molecule modulators of immune pattern recognition receptors
Taku Tsukidate, Charles W. Hespen, Howard C. Hang
RSC Chemical Biology (2023) Vol. 4, Iss. 12, pp. 1014-1036
Open Access | Times Cited: 11
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology
Liqi He, Meng Yao Zhang, Matthew Cox, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 189-196
Closed Access | Times Cited: 3
Recent Advances in Studying Toll-like Receptors with the Use of Computational Methods
Maria Bzówka, Weronika Bagrowska, Artur Góra
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 12, pp. 3669-3687
Open Access | Times Cited: 9
Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation
Liuwei Gu, Xiaojie Kong, Mengyan Li, et al.
Chemical Communications (2024) Vol. 60, Iss. 42, pp. 5474-5485
Closed Access | Times Cited: 2
Discovery and Evaluation of TLR-Targeted Immune Agonists
Natalia Chernyak, Bhagyashree Bhagwat, Saraswathi Naravula, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16222-16234
Closed Access | Times Cited: 2
Chemical reagents modulate nucleic acid-activated toll-like receptors
Xiao Li, Xinyuan Sun, Xuemin Guo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112622-112622
Open Access | Times Cited: 10
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits
Nirmal K. Das, Purbita Bandopadhyay, Swarnali Roy, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11607-11632
Closed Access | Times Cited: 9
Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists
Nika Strašek Benedik, Ana Dolšak, Urban Švajger, et al.
ACS Omega (2024) Vol. 9, Iss. 2, pp. 2362-2382
Open Access | Times Cited: 1
Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists
Sourav Pal, Uddipta Ghosh Dastidar, Trisha Ghosh, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4026-4026
Open Access | Times Cited: 8
Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma.
Abdulraheem Gul Mohammad, Dapeng Li, Rong He, et al.
PubMed (2022) Vol. 14, Iss. 4, pp. 2501-2526
Closed Access | Times Cited: 8
Mitigating hERG Liability of Toll‐Like Receptor 9 and 7 Antagonists through Structure‐Based Design
Nirmal K. Das, Debomita Bhattacharya, Purbita Bandopadhyay, et al.
ChemMedChem (2023) Vol. 18, Iss. 12
Closed Access | Times Cited: 3
Call for Papers: Medicinal Chemistry of Next Generation Vaccine Adjuvants
Deepak B. Salunke, Craig W. Lindsley
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10119-10121
Open Access | Times Cited: 3
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an In Vivo Efficacious TLR7/8 Antagonist
Claudia Betschart, Michael Faller, F. Zink, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 4, pp. 658-664
Open Access | Times Cited: 5
Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker
Lydia Bisbal Lopez, Domenico Ravazza, Matilde Bocci, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of New 2,6,7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants
M.-K. Kim, Kyungseob Noh, Pyeongkeun Kim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9389-9405
Closed Access
Page 1 - Next Page

Scroll to top